Provide unique methods for successful theragnostic advantages.

Small Particles,
Large Benefits

Nanoparticles uniquely visible in echo, MRI, CT, and fluorescence for faster, lower cost
trials with increased discriminate visibility and accuracy/intensity, therapeutic drug delivery, payload targeted for timely release and precise dosage. Multi-drug options are available for either simultaneous or cascading drug delivery.

Learn More

Global Leader in Nanoparticle Technology

Based on nanoparticle technology, our distinctive engineered platform has been used in a variety of biomedical applications. In cancer, NanoMedtrix material has been designed to target solid tumors such as: bladder, colorectal and neural tumors. The same nano-compounds are adjustable to provide valuable information on the disease process of multitude illnesses. REDUCING THE TIME AND COST OF SCIENTIFIC TRIALS

About Nanomedtrix

Unveiling the Science Behind Our Innovative Particles

NanoMedTrix develops novel multi-modal, targeted contrast agents MSNs for use across a range of disciplines, including regenerative technology and targeted radiological medical imaging. Contrast agents are co-crystalized in the particles and used to enhance the visibility of structures or fluids in the body during scans, such as MRI, CT and ultrasound. The manufactured intentionally void space within the particles allows payloads of diverse bioactive substances.

Diseases, such as bladder cancer, benefit from nanotechnology-based treatment as particles are able to reach muscle-invaded layers.

Ultrasound (HRS ) image of an mouse animal model of bladder cancer. Other models rat, dog have been tested. Tumors in this specimen were inserted and were treated with particles-drug. The tumor disappeared.

Learn More

Revolutionize Your Trials with Faster, More Accurate Results at a Lower Cost

Our products are based on nanoparticle technology, which allows to create products that are simple and easy-to-use, combining fluorescence, magnetic resonance imaging (MRI) and/or computed tomography (CT) with ultrasound imaging signaling capability. This allows for visual seamless non-invasive validation from in vitro specimens to in vivo transplanted models.

Repeated, timed evaluation and measurements can be obtained non-invasively, providing a programmable, scheduled data acquisition, reducing cost and time per trial. Computational Imaging and pharmacokinetic studies can be combined for more powerful/convincing scientific evidence.

In Applications

Preclinical Studies

Our products have been used in preclinical (animal) studies to assess the safety and efficacy of new drugs and treatments. NMTx has developed animal models for cancer and other major diseases and with collaborating research institutions has established state of the art PK and PD evaluation strategies.

Clinical Studies

Our products are currently being evaluated for clinical studies to assess their safety and efficacy. Both xenografts, human tissue and images have been used to determine toxicity and potentials of our nanoparticles for human.

Learn More